Waters Corp Fourth Quarter Earnings Sneak Peek

S&P 500 (NYSE:SPY) component Waters Corp (NYSE:WAT) will unveil its latest earnings on Tuesday, January 24, 2012. Waters is an analytical instrument manufacturer that designs, manufactures, sells and services liquid chromatography, ultra performance liquid chromatography, mass spectrometry instrument systems, and support products.

Waters Corp Earnings Preview Cheat Sheet.

Wall St. Earnings Expectations: The average estimate of analysts is for net income of $1.50 per share, a rise of 8.7% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from $1.55. Between one and three months ago, the average estimate moved down. It has been unchanged at $1.50 during the last month. Analysts are projecting profit to rise by 16.1% versus last year to $4.75.

Last quarter, the company came in at profit of $1.14 per share against a mean estimate of net income of $1.13 per share, beating estimates after missing them in the previous quarter. In the second quarter, it missed forecasts by 6 cents.

Investing Insights: Will the iPad 3 Be the Next Catalyst for Apple’s Stock?

Wall St. Revenue Expectations: Analysts are projecting a rise of 7% in revenue from the year-earlier quarter to $517.5 million.

Analyst Ratings: Analysts are bullish on this stock with 11 analysts rating it as a buy, none rating it as a sell and five rating it as a hold.

A Look Back: In the third quarter, profit rose 6.9% to $101.3 million ($1.10 a share) from $94.7 million ($1.02 a share) the year earlier, exceeding analyst expectations. Revenue rose 13.3% to $454.5 million from $401 million.

Key Stats:

The company has enjoyed double-digit year-over-year percentage revenue growth for the past four quarters. Over that span, the company has averaged growth of 14.2%, with the biggest boost coming in the first quarter when revenue rose 16.3% from the year earlier quarter.

The company has seen net income rise in three straight quarters. Net income rose 17.8% in the second quarter and 25.1% in the first quarter.

Competitors to Watch: Bruker Corporation (NASDAQ:BRKR), Dionex Corporation (NASDAQ:DNEX), Transgenomic, Inc. (TBIO), Beckman Coulter, Inc. (NYSE:BEC), PerkinElmer, Inc. (NYSE:PKI), Thermo Fisher Scientific Inc. (NYSE:TMO), Bio-Rad Laboratories, Inc. (NYSE:BIO), Harvard Bioscience, Inc. (NASDAQ:HBIO), Cepheid (NASDAQ:CPHD), and Mettler-Toledo Intl. Inc. (NYSE:MTD).

Stock Price Performance: During December 16, 2011 to January 18, 2012, the stock price had risen $4.68 (6.5%) from $71.61 to $76.29. The stock price saw one of its best stretches over the last year between March 23, 2011 and April 5, 2011 when shares rose for 10-straight days, rising 6.7% (+$5.65) over that span. It saw one of its worst periods between December 6, 2011 and December 14, 2011 when shares fell for seven-straight days, falling 10.4% (-$8.33) over that span.

(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)

Investing Insights: Will the iPad 3 Be the Next Catalyst for Apple’s Stock?

To contact the reporter on this story: Derek Hoffman at staff.writers@wallstcheatsheet.com

To contact the editor responsible for this story: Damien Hoffman at editors@wallstcheatsheet.com